Andrew Gundlach
Andrew Gundlach was appointed Executive Chairman of the Board and resigned as President and Chief Executive Officer of the Company, effective April 29, 2026
Highest-materiality recent filing
Bleichroeder and Pasqal amend merger deal, boost PIPE to $250M, file F-4
Amendment assigns merger sub to New Merger Sub; updates transaction structure and definitions.
Andrew Gundlach resigned as President and CEO, appointed Executive Chairman effective April 29, 2026.
Bleichroeder Acquisition Corp. II to combine with Pasqal at $2.0B pre-money valuation
Deal values Pasqal at $2.0B pre-money; Pasqal shareholders to receive New Pasqal shares.
Bleichroeder Acquisition Corp. II appoints Philippe Nyssen and Clemence Rasigni as directors
Appointments effective February 10, 2026; both qualify as independent directors.
Effective Jan 28, 2026, unit holders may separately trade Class A ordinary shares (BBCQ) and warrants (BBCQW).
Bleichroeder Acquisition Corp. II closes IPO of 28.75M units at $10.00, raising $287.5M
Sold 28,750,000 units at $10.00/unit, including full exercise of over-allotment (3.75M units), gross proceeds $287.5M.
Bleichroeder Acquisition Corp. II closes $287.5M IPO; 28.75M units at $10.00
Gross proceeds of $287.5M from IPO (28.75M units including full over-allotment) and private placement; $287.5M deposited in trust.
Andrew Gundlach was appointed Executive Chairman of the Board and resigned as President and Chief Executive Officer of the Company, effective April 29, 2026
Marcello Padula, the Company’s currently serving Chief Operating Officer, was appointed to serve as Chief Executive Officer of the Company, effective April 29, 2026
Andrew Gundlach was appointed Executive Chairman of the Board and resigned as President and Chief Executive Officer of the Company, effective April 29, 2026
Max materiality 0.80 · Median 0.50 · Most common event m_and_a